R. Levin

发表

Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.

C. Roehrborn, K. McVary, J. Ulchaker, 2016, The journal of sexual medicine.

One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume® Drug-Coated Balloon for Anterior Urethral Strictures

C. Olsson, S. Elliott, S. Brandes, 2021, The Journal of urology.

JU Insight One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume Drug-Coated Balloon for Anterior Urethral Strictures

S. Elliott, S. Brandes, B. Erickson, 2021 .

Convective Thermal Therapy: Durable 2‐Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

C. Roehrborn, K. McVary, J. Ulchaker, 2017, The Journal of urology.

Transurethral Vapor Ablation in Patients with Intermediate Risk Localized Prostate Cancer.

M. White, B. Spilseth, C. Dixon, 2022, Journal of endourology.

Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.

C. Higano, R. Dreicer, C. Stein, 2018, Urologic oncology.

Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results

J. Epstein, S. Kaplan, N. Shore, 2020, World Journal of Urology.

Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

C. Roehrborn, K. McVary, J. Ulchaker, 2016, The Journal of urology.

Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

C. Roehrborn, K. McVary, J. Ulchaker, 2021, The Journal of urology.

CONVECTIVE RADIOFREQUENCY THERMAL THERAPY: DURABLE TWO‐YEAR OUTCOMES OF A RANDOMIZED CONTROLLED AND PROSPECTIVE CROSSOVER STUDY TO RELIEVE LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: PD23‐10

C. Roehrborn, K. McVary, J. Ulchaker, 2017 .

PII-LBA1 USING THE THERMAL ENERGY OF CONVECTIVELY DELIVERED WATER VAPOR FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: THE REZUM II STUDY

C. Roehrborn, K. McVary, J. Ulchaker, 2015 .

Preliminary analysis of a U.S. phase II study of the safety and tolerability of proxalutamide (GT0918) in subjects with mCRPC who had progressed on either abiraterone (Abi) or enzalutamide (Enza).

A. Ross, N. Vogelzang, N. Gabrail, 2021 .